Page last updated: 2024-11-02

pd 98059 and Nerve Degeneration

pd 98059 has been researched along with Nerve Degeneration in 7 studies

2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.

Nerve Degeneration: Loss of functional activity and trophic degeneration of nerve axons and their terminal arborizations following the destruction of their cells of origin or interruption of their continuity with these cells. The pathology is characteristic of neurodegenerative diseases. Often the process of nerve degeneration is studied in research on neuroanatomical localization and correlation of the neurophysiology of neural pathways.

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's5 (71.43)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zheng, W1
Chong, CM1
Wang, H1
Zhou, X1
Zhang, L1
Wang, R1
Meng, Q1
Lazarovici, P1
Fang, J1
Frasca, G1
Chiechio, S1
Vancheri, C1
Nicoletti, F1
Copani, A1
Angela Sortino, M1
Maier, K1
Rau, CR1
Storch, MK1
Sättler, MB1
Demmer, I1
Weissert, R1
Taheri, N1
Kuhnert, AV1
Bähr, M1
Diem, R1
Jiang, W1
Van Cleemput, J1
Sheerin, AH1
Ji, SP1
Zhang, Y1
Saucier, DM1
Corcoran, ME1
Zhang, X1
Rundén, E1
Seglen, PO1
Haug, FM1
Ottersen, OP1
Wieloch, T1
Shamloo, M1
Laake, JH1
Rapoport, M1
Ferreira, A1
Gu, Z1
Jiang, Q1
Zhang, G1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Double Blind, Placebo-controlled Study to Determine the Safety and Efficacy of Erythropoietin as an add-on Therapy of Methylprednisolone in Subjects With Acute Optic Neuritis (VISION PROTECT)[NCT00355095]Phase 240 participants (Actual)Interventional2006-08-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

7 other studies available for pd 98059 and Nerve Degeneration

ArticleYear
Artemisinin conferred ERK mediated neuroprotection to PC12 cells and cortical neurons exposed to sodium nitroprusside-induced oxidative insult.
    Free radical biology & medicine, 2016, Volume: 97

    Topics: Animals; Artemisinins; Cell Death; Cell Survival; Chromones; Flavonoids; MAP Kinase Signaling System

2016
Beta-amyloid-activated cell cycle in SH-SY5Y neuroblastoma cells: correlation with the MAP kinase pathway.
    Journal of molecular neuroscience : MN, 2004, Volume: 22, Issue:3

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Apoptosis; Cell Cycle; Cell Cycle Proteins; Cell Different

2004
Ciliary neurotrophic factor protects retinal ganglion cells from secondary cell death during acute autoimmune optic neuritis in rats.
    Brain pathology (Zurich, Switzerland), 2004, Volume: 14, Issue:4

    Topics: Analysis of Variance; Animals; bcl-2-Associated X Protein; Blotting, Western; Cell Count; Cell Death

2004
Involvement of extracellular regulated kinase and p38 kinase in hippocampal seizure tolerance.
    Journal of neuroscience research, 2005, Aug-15, Volume: 81, Issue:4

    Topics: Animals; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Hippocampus; Imi

2005
Regional selective neuronal degeneration after protein phosphatase inhibition in hippocampal slice cultures: evidence for a MAP kinase-dependent mechanism.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 1998, Sep-15, Volume: 18, Issue:18

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Antioxidants; Apoptosis; Benzylamines; Calci

1998
PD98059 prevents neurite degeneration induced by fibrillar beta-amyloid in mature hippocampal neurons.
    Journal of neurochemistry, 2000, Volume: 74, Issue:1

    Topics: Amyloid beta-Peptides; Animals; Cellular Senescence; Enzyme Activation; Enzyme Inhibitors; Flavonoid

2000
Extracellular signal-regulated kinase 1/2 activation in hippocampus after cerebral ischemia may not interfere with postischemic cell death.
    Brain research, 2001, May-18, Volume: 901, Issue:1-2

    Topics: Animals; Brain Ischemia; Cell Death; Cell Survival; Enzyme Inhibitors; Flavonoids; Hippocampus; Immu

2001